Literature DB >> 3678700

Platelet-activating factor: an endogenous mediator for bowel necrosis in endotoxemia.

W Hsueh1, F González-Crussi, J L Arroyave.   

Abstract

We have developed a model of isochemic bowel necrosis in the rat by injecting platelet-activating factor (PAF) or PAF in combination with bacterial endotoxin. PAF causes profound hypotension, and it has been suggested that it is released during endotoxin shock. Because ischemic bowel necrosis is often associated with shock or infection, it is possible that PAF is the endogenous mediator that causes shock and bowel necrosis during sepsis. In this study, we have demonstrated that: 1) normal intestine contained a small amount of PAF; 2) necrotic lesions of the intestine could be induced by endotoxin injection; 3) PAF production in the bowel is markedly increased in animals treated with endotoxin; 4) pretreatment of the animal with PAF antagonists prevent endotoxin-induced necrosis; 5) isolated, buffer-perfused small intestine produced a small quantity of PAF in response to endotoxin injection. Therefore, we conclude that PAF is a likely endogenous mediator in endotoxemia, which causes bowel necrosis and shock.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3678700     DOI: 10.1096/fasebj.1.5.3678700

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  42 in total

1.  Platelet-activating factor modulates endotoxin-induced macrophage procoagulant activity by a protein kinase C-dependent mechanism.

Authors:  D S Kucey; P Y Cheung; O D Rotstein
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

2.  Bowel necrosis induced by tumor necrosis factor in rats is mediated by platelet-activating factor.

Authors:  X M Sun; W Hsueh
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

3.  TGF-β2 suppresses macrophage cytokine production and mucosal inflammatory responses in the developing intestine.

Authors:  Akhil Maheshwari; David R Kelly; Teodora Nicola; Namasivayam Ambalavanan; Sunil K Jain; Joanne Murphy-Ullrich; Mohammad Athar; Masako Shimamura; Vineet Bhandari; Charles Aprahamian; Reed A Dimmitt; Rosa Serra; Robin K Ohls
Journal:  Gastroenterology       Date:  2010-09-24       Impact factor: 22.682

4.  Inflammatory signaling in NEC: Role of NF-κB, cytokines and other inflammatory mediators.

Authors:  Catherine J Hunter; Isabelle G De Plaen
Journal:  Pathophysiology       Date:  2013-12-31

5.  The role of xanthine oxidase in platelet activating factor induced intestinal injury in the rat.

Authors:  X W Qu; R A Rozenfeld; W Huang; G B Bulkley; W Hsueh
Journal:  Gut       Date:  1999-02       Impact factor: 23.059

6.  Pathophysiology of experimental bovine endotoxicosis: endotoxin induced synthesis of prostaglandins and thromboxane and the modulatory effect of some non-steroidal anti-inflammatory drugs.

Authors:  N Jarløv; P H Andersen; M Hesselholt
Journal:  Acta Vet Scand       Date:  1992       Impact factor: 1.695

Review 7.  Inflammatory signaling in necrotizing enterocolitis.

Authors:  Isabelle G De Plaen
Journal:  Clin Perinatol       Date:  2013-01-17       Impact factor: 3.430

8.  Interaction of platelet-activating factor, spleen and atrial natriuretic peptide in plasma volume regulation during endotoxaemia in rats.

Authors:  X W Qu; R A Rozenfeld; W Huang; S E Crawford; F Gonzalez-Crussi; W Hsueh
Journal:  J Physiol       Date:  1998-10-01       Impact factor: 5.182

9.  Tumour necrosis factor and endotoxin synergistically activate intestinal phospholipase A2 in mice. Role of endogenous platelet activating factor and effect of exogenous platelet activating factor.

Authors:  X Sun; M S Caplan; W Hsueh
Journal:  Gut       Date:  1994-02       Impact factor: 23.059

10.  Platelet-activating factor induces TLR4 expression in intestinal epithelial cells: implication for the pathogenesis of necrotizing enterocolitis.

Authors:  Antoine Soliman; Kathrin S Michelsen; Hisae Karahashi; Jing Lu; Fan Jing Meng; Xiaowu Qu; Timothy R Crother; Shervin Rabizadeh; Shuang Chen; Michael S Caplan; Moshe Arditi; Tamas Jilling
Journal:  PLoS One       Date:  2010-10-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.